Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Novo Nordisk’s GLP-1 drug Wegovy shows early protection against heart disease

Heart and circulatory diseases are responsible for more than 170,000 deaths in the UK every year

- PMLiVE

Transforming Global Market Access: Smarter Resource Management with Local Affiliates – A Live Webinar

Are your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? Join us live at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Wednesday 21st May, to discover how...

Petauri Evidence

New team members

Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning

Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.

Cuttsy + Cuttsy

- PMLiVE

FDA approves Verastem Oncology’s combination therapy for rare ovarian cancer type

Approximately 6,000 to 8,000 women in the US are living with low-grade serous ovarian cancer

- PMLiVE

J&J/Protagonist’s icotrokinra shows promise in difficult-to-treat plaque psoriasis

An estimated eight million people in the US are living with the immune-mediated skin disease

- PMLiVE

GSK shares promising phase 3 results for linerixibat in PBC-related itch

Pruritus is experienced by up to 90% of patients with the rare liver disease

- PMLiVE

Shaping the Future of Hematology and Women’s Health

Changes in the healthcare world are likely to limit opportunities for young researchers, especially women.Three leaders in hematology — Belinda Avalos, Sarah O’Brien, and Marty Liggett — share the initiatives...

Medscape Education

- PMLiVE

BeiGene’s Tevimbra combination granted EC approval in small cell lung cancer

Approximately 15% of all lung cancer patients are diagnosed with the aggressive disease

- PMLiVE

Inizio Evoke appoints Tristen George and Kevin Kaniuga as executive creative directors

The dual appointments are aimed at strengthening Evoke’s creative leadership

- PMLiVE

AstraZeneca/Daiichi Sankyo share positive phase 3 results for Enhertu in early breast cancer

Around one in three patients with early-stage breast cancer are considered high risk

- PMLiVE

FDA announces rapid rollout of AI system to accelerate drug review process

The move follows the completion of a new AI-assisted scientific review pilot

The (clinical) trials and tribulations of gene therapy – why meaningful patient engagement strategies matter

By Sarah Mohamad and Lauren Coleman-Bennett

Amiculum

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links